Direct-from-Specimen Pathogen Identification : Evolution of Syndromic Panels - 03/08/19
Doi : 10.1016/j.cll.2019.05.005
Marc Roger Couturier, PhD, D(ABMM) a, ⁎ 
, Jennifer Dien Bard, PhD, D(ABMM) b
, Jennifer Dien Bard, PhD, D(ABMM) b a ARUP Laboratories, University of Utah, 500 Chipeta Way, Salt Lake City, UT 84108, USA
b Microbiology and Virology Laboratories, Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, University of Southern California, 4650 Sunset Boulevard MS#32, Los Angeles, CA 90027, USA
∗Corresponding author.
Résumé |
This article describes the current state of the art with regards to commercially available syndromic panels for blood stream infections, gastrointestinal pathogen detection, respiratory tract infections, and central nervous system infections, while providing a provocative and speculative look into the future of syndromic panel testing for infectious diseases.
Le texte complet de cet article est disponible en PDF.Keywords : Syndromic panel, Respiratory panel, Sepsis panel, Gastroenteritis panel, Meningitis panel, Encephalitis panel
Plan
| Disclosure Statement: M.R. Couturier receives household income from BioFire diagnostics and is involved in clinical trials activities with Luminex (Verigene). J.D. Bard is a consultant for BioFire Diagnostics and Accelerate Diagnostics and is involved in clinical trials activities with BioFire Diagnostics, Luminex Corporation and DiaSorin Molecular. |
© 2019
Elsevier Inc. Tous droits réservés.
Vol 39 - N° 3
P. 433-451 - septembre 2019 Retour au numéro
Article précédent
- Distributed Microbiology Testing : Bringing Infectious Disease Diagnostics to Point of Care
- David R. Peaper, Thomas Durant, Sheldon Campbell
- Predicting Bacterial Versus Viral Infection, or None of the Above : Current and Future Prospects of Biomarkers
- Stefan Riedel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?